LABTVSSLXN• 12 Months (Normalized)
LABT vs SLXN (Lakewood-Amedex Biotherapeutics Inc. vs Silexion Therapeutics Corp)
Showing Closing Date Range from Oct 1, 2025 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $0.99
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
SLXN Performance $0.28
-99.27%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin LABT LEADS
+99.27 pts
LABT outperforming by 99.27 percentage points
LABTSLXN
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | LABT Price | LABT Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $- | $0.28 | -99.27% | - | |
| Sep 29, 2026 | $0.99 | -98.86% | $0.32 | -99.16% | +0.30% |
| Sep 28, 2026 | $1.15 | -98.67% | $0.25 | -99.35% | +0.68% |
| Sep 25, 2026 | $1.67 | -98.07% | $0.26 | -99.31% | +1.24% |
| Sep 24, 2026 | $1.83 | -97.88% | $0.26 | -99.32% | +1.44% |
| Sep 23, 2026 | $1.78 | -97.94% | $0.32 | -99.17% | +1.23% |
| Sep 22, 2026 | $1.99 | -97.70% | $0.39 | -98.97% | +1.27% |
| Sep 21, 2026 | $2.05 | -97.63% | $0.54 | -98.56% | +0.93% |
| Sep 18, 2026 | $1.99 | -97.70% | $0.44 | -98.85% | +1.15% |
| Sep 17, 2026 | $1.86 | -97.85% | $0.38 | -99.00% | +1.15% |
| Sep 16, 2026 | $2.09 | -97.58% | $0.34 | -99.10% | +1.52% |
| Sep 15, 2026 | $2.17 | -97.49% | $0.34 | -99.10% | +1.61% |
| Sep 14, 2026 | $2.12 | -97.55% | $0.39 | -98.98% | +1.43% |
| Sep 11, 2026 | $2.22 | -97.43% | $0.36 | -99.06% | +1.63% |
| Sep 10, 2026 | $2.05 | -97.63% | $0.42 | -98.88% | +1.25% |
Page 1 of 17